Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ · Healthcare
Cumberland Pharmaceuticals Inc. Revenue 2009–2025
Cumberland Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cumberland Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 9.1 M, a 22.04% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 40.0 M, a 6.55% increase year-over-year.
- Cumberland Pharmaceuticals Inc. annual revenue for 2025 was 44.5 M, a 17.57% increase from 2024.
- Cumberland Pharmaceuticals Inc. annual revenue for 2024 was 37.9 M, a 4.26% decrease from 2023.
- Cumberland Pharmaceuticals Inc. annual revenue for 2023 was 39.6 M, a 5.85% decrease from 2022.
- Cumberland Pharmaceuticals Inc. annual revenue for 2022 was 42.0 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cumberland Pharmaceuticals Inc. Market Cap — FAQ
Cumberland Pharmaceuticals Inc. (CPIX) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPIX's market cap history?
The chart and table above show Cumberland Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.